BUFFALO, NY — Yeong “Christopher” Choi, PhD, has joined Roswell Park Cancer Institute (RPCI) as Director of the newly created Therapeutic Cell Production Facility, a critical component of RPCI’s Center for Immunotherapy. The facility is the first of its kind in the Western New York region. The objective of the center is to accelerate efforts to bring effective immune-based therapies to cancer patients sooner, explains Kunle Odunsi, MD, PhD, Chair of the Department of Gynecologic Oncology and Director of the Center for Immunotherapy. “One promising approach is the use of immune cells directly harvested from cancer patients. The cells are expanded and manipulated in a ‘clean’ facility, and given back to patients in order to fight their cancer,” says Dr. Odunsi. “The Therapeutic Cell Production Facility will prepare these immune cells, and take appropriate steps to ensure that they can be safely administered to our patients. It will allow us to deliver these cutting-edge, innovative treat...